Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aymeric Basset

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Brain : a Journal of Neurology|May 16, 2025
Linking polygenic risk scores to dopaminergic neuron loss using neuromelanin-sensitive imagingAymeric Lanore, Rahul Gaurav, François-Xavier Lejeune, et al.
British Journal of Haematology|December 27, 2021
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemiaThomas Coats, Daniel Bean, Aymeric Basset, et al.
NPJ Parkinson'S Disease|August 2, 2025
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Brain : a Journal of Neurology|May 16, 2025
Linking polygenic risk scores to dopaminergic neuron loss using neuromelanin-sensitive imagingAymeric Lanore, Rahul Gaurav, François-Xavier Lejeune, et al.
British Journal of Haematology|December 27, 2021
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemiaThomas Coats, Daniel Bean, Aymeric Basset, et al.
NPJ Parkinson'S Disease|August 2, 2025
Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysisAymeric Lanore, Christelle Tesson, Aymeric Basset, et al.
BMJ Neurology Open|January 21, 2026
Understanding dopaminergic dose reduction following STN-DBS: mediation analysisAymeric Lanore, Marion Houot, Aymeric Basset, et al.
Pageof 1